The New York Times - May 21, 2009
Doreen Carvajal
"If we get broad-based support, there is no telling what we can do," Mr. Clinton said Wednesday at a news conference in Paris, alongside Philippe Douste-Blazy, a development-financing adviser to the U.N. secretary general, Ban Ki-moon.
"If you provide a user-friendly, efficient way of giving, the contributors will use this system. There's no question that large numbers of people will contribute if they know how little it costs and how many lives are saved."
The United Nations is trying to tap new sources of revenue during the global economic crisis, turning to travelers who are willing to check off a $2 donation added to their ticket prices. The aim is to increase government aid for projects to fight malaria, tuberculosis and AIDS, according to both men, who are working with a newly formed group -- Leading Innovative Financing for Equity, or LIFE -- made up of eight different groups that are raising money to finance health aid.
One of those organizations is Unitaid, a Geneva organization founded in 2006 that is financed by airline ticket taxes in 7 of its 35 member nations. The group has raised and committed more than $900 million for treatment. Its aim is to buy medications in high volume in order to negotiate low prices.
The campaign to tap small donors will not be operating until January, said Mr. Douste-Blazy, who explained that "the idea is that the citizens of the world are connected by the Internet and credit cards and can show their solidarity." In the meantime, the groups have set broader goals to reach those renting cars, booking hotels or buying train tickets.
Such measures will be coordinated by the group, LIFE, along with other financing arrangements like the sale of child vaccine bonds. The International Finance Facility for Immunization -- backed by Britain, Italy, France, Spain, Sweden, Norway and South Africa -- has already raised more than $2 billion since 2006 by selling vaccine bonds on the capital markets.
090521
NYT090512
Copyright © 2009 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .